Zoetis inc stock.

Zoetis Inc. : Forcasts, revenue, earnings, analysts expectations, ratios for Zoetis Inc. Stock | ZTS | US98978V1035Zoetis Inc. Class A Common Stock (ZTS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Price Performance Review of ZTS. On Friday, Zoetis Inc [NYSE:ZTS] saw its stock jump 0.82% to $162.23. On the same session, the stock had its day’s lowest price of $159.37, but rose to a high of $164.72. Over the last five days, the stock has gained 3.97%. Zoetis Inc shares have risen nearly 10.70% since the year began.Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.Zoetis Inc. (ZTS Quick Quote ZTS - Free Report) will report fourth-quarter and full-year 2022 results on Feb 14, 2023, ... EQRx’s stock has plunged 30.7% in the past year.

Get the latest Chewy Inc (CHWY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Net Income Attributable to Zoetis $ 1,638 $ 2,037 $ 2,114 Adjusted Net Income Attributable to Zoetis† $ 1,844 $ 2,240 $ 2,297 Diluted Earnings Per Share $ 3.42 $ 4.27 $ 4.49 Adjusted ... of-stock situations. Across our global manufacturing and supply network of 29 sites, we are deploying the technology,Zoetis | 394,115 followers on LinkedIn. Nurturing our world and humankind by advancing care for animals | As the world’s leading animal health company, Zoetis is driven by a singular purpose: to ...

Zoetis Inc. (NYSE:ZTS) posted its quarterly earnings data on Tuesday, August, 8th. The company reported $1.41 earnings per share for the quarter, topping analysts' consensus estimates of $1.31 by $0.10. The business earned $2.18 billion during the quarter, compared to the consensus estimate of $2.16 billion.Feb 8, 2023 · Zoetis Declares Second Quarter 2023 Dividend. February 8, 2023. PARSIPPANY, N.J.-- (BUSINESS WIRE)-- The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the second quarter of 2023. The dividend will be paid on Thursday, June 1, 2023, to all holders of record of the Company’s common stock as of the ... The company reported revenue of $2.0 billion for the third quarter of 2022, an increase of 1% compared with the third quarter of 2021. Net income for the third quarter of 2022 was $529 million, or $1.13 per diluted share, a decrease of 4% and 3%, respectively, on a reported basis. On an operational 1 basis, revenue for the third quarter of 2022 ...Ex-Dividend Date. Record Date. Payable Date. Amount Per Share. 10/31/2023. 11/01/2023. 12/01/2023. $0.38. 07/20/2023.Get the latest stock price for Zoetis Inc. Class A (ZTS:US), plus the latest news, recent trades, charting, insider activity, and analyst ratings.

$7.4 million in corporate giving invested in communities, and an additional $5.7 million distributed through Zoetis Foundation grants to support veterinarians and farmers Continued progress toward colleague diversity aspirations, including increased representation of women at the director level and above globally from 32% in 2020 to …

View Zoetis Inc ZTS investment & stock information. Get the latest Zoetis Inc ZTS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

The public float for ZTS is 458.79M, and at present, short sellers hold a 0.66% of that float. On November 29, 2023, the average trading volume of ZTS was 1.84M shares. ZTS) stock’s latest price update. The stock of Zoetis Inc (NYSE: ZTS) has decreased by -1.02 when compared to last closing price of 178.79.Zoetis Inc. (ZTS Quick Quote ZTS - Free Report) reported first-quarter 2023 adjusted earnings (excluding one-time items) of $1.31 per share, which beat the Zacks Consensus Estimate and our model ...Nov 29, 2023 · The high in the last 52 weeks of Zoetis stock was 194.99. According to the current price, Zoetis is 90.29% away from the 52-week high. What are analysts forecasts for Zoetis stock? Discover historical prices for ZTS stock on Yahoo Finance. View daily, weekly or monthly format back to when Zoetis Inc. stock was issued. ... Zoetis Inc. (ZTS) NYSE - Nasdaq Real Time Price ...You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.ZTS | Complete Zoetis Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Zoetis Announces First Quarter 2022 Results. Reports Revenue of $2.0 Billion, Growing 6%, and Net Income of $595 Million, or $1.26 per Diluted Share, Increasing 6% and 8%, Respectively, on a Reported Basis for First Quarter 2022. Delivers 9% Operational Growth in Revenue and 8% Operational Growth in Adjusted Net Income for First Quarter 2022.

Nov 4, 2021 · PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE: ZTS) today reported its financial results for the third quarter of 2021 and increased its guidance for full year 2021. The company reported revenue of $2.0 billion for the third quarter of 2021, an increase of 11% compared with the third quarter of 2020. Zoetis is a component of the S&P 500 and has roughly 13,800 employees. Analyst Report: Zoetis Inc Zoetis Inc., a 2013 spinoff from Pfizer, focuses on the development, manufacture and ...May 4, 2023 · Zoetis Announces First Quarter 2023 Results. May 4, 2023. Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $552 Million, or $1.19 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for First Quarter 2023. Delivers 4% Operational Growth in Revenue and a 3% Operational Decline in Adjusted Net Income for First ... Zoetis ( ZTS 0.35%) is a leader in the pharmaceutical market for pets and livestock. It used to be a part of Pfizer ( PFE 0.07%), but was spun off in 2012. What makes Zoetis's business attractive ...For Fourth Quarter 2021, Zoetis Reports Revenue of $2.0 Billion, Growing 9%, and Net Income of $414 Million, or $0.87 per Diluted Share, on a Reported Basis Reports Adjusted Net Income of $474 Million, or Adjusted Diluted EPS of $1.00, for Fourth Quarter 2021 Delivers 9% Operational Growth in Revenue and 5% Operational Growth in Adjusted Net …The estimated Net Worth of Paul Bisaro is at least $38.1 Million dollars as of 14 March 2023. Mr. Bisaro owns over 5,000 units of Zoetis Inc stock worth over $13,665,873 and over the last 10 years he sold ZTS stock worth over $24,032,600. In addition, he makes $355,000 as Independent Director at Zoetis Inc.2 nov 2023 ... Zoetis Inc. reports revenue of $2.2 billion, growing 7% in Q3 2023. Net income increases 13% to $596 million. Adjusted net income reaches ...

Zoetis Inc. Class A Common Stock (ZTS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Benefits. Revolution Plus is the most prescribed medicine for feline parasite protection1. Building on the legacy of Revolution® (selamectin), Revolution Plus is now the trusted choice. Revolution Plus is an all-in-one solution—one application a month defends against roundworms, hookworms, and heartworm disease plus has a unique dual action ...

Zoetis Inc. (NYSE: ZTS) is a company that has got both marketing and innovation right in the last decade, which has led to a 4-fold growth in net income since 2013. The company has continued to ...View the latest Zoetis Inc. (ZTS) stock price, news, historical charts, analyst ratings and financial information from WSJ.Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing.According to the issued ratings of 6 analysts in the last year, the consensus rating for Zoetis stock is Buy based on the current 6 buy ratings for ZTS. The average twelve-month price prediction for Zoetis is $216.29 with a high price target of $260.00 and a low price target of $195.00. Learn more on ZTS's analyst rating history.Zoetis Declares Fourth Quarter 2023 Dividend. PARSIPPANY, N.J., October 12, 2023--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the fourth ...Select year: 11/02/2023 8:30 AM ET. Zoetis Quarterly Corporate Performance - Third Quarter 2023. Webcast. Presentation. 09/12/2023 12:55 PM ET. Morgan Stanley 21st Annual Global Healthcare Conference.On February 5, 2023, Zoetis terminated Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at Zoetis Inc. (the "Company"), for violating company policy by engaging in a consensual personal relationship and failing to disclose it to the Company. Mr.

Get the latest stock price for Zoetis Inc. Class A (ZTS:US), plus the latest news, recent trades, charting, insider activity, and analyst ratings.

Zoetis. Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [5] [4] [6] The company was a subsidiary of Pfizer, [7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.

Zoetis Inc (ZTS) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. 🚀 Enjoy a 7-Day Free Trial Thru Dec 07, 2023! Sign UpZTS - Zoetis Inc. Basic Chart, ... Zoetis stock jump 5% after earnings beat and upbeat guidance MarketWatch. Thursday, January 19, 2023. 12:55 PM ET. Finance Chiefs Hope New Congress Will Revisit Tax Rule on R&D Expenses The Wall Street Journal Interactive Edition.Investors are eagerly awaiting Zoetis Inc’s upcoming earnings report, scheduled to be released on August 8. This report will provide further insights into the company’s financial performance and may impact the stock’s future trajectory. Overall, Zoetis Inc’s stock performance on July 3, 2023, indicates a positive outlook for the …Jamie Brannan ZTS stock SEC Form 4 insiders trading. Jamie has made over 1 trades of the Zoetis Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Jamie exercised 391 units of ZTS stock worth $66,716 on 11 February 2023.. The largest trade Jamie's ever made was exercising 391 units of Zoetis Inc stock …Zoetis Inc. (ZTS) Outperforms Peers and Shows Promising Growth: A Strong Buy Recommendation November 3, 2023TipRanks. Zoetis price target lowered to $255 from $260 at Barclays November 3 ...Nicholas Ashton ZTS stock SEC Form 4 insiders trading. Nicholas has made over 1 trades of the Zoetis Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Nicholas exercised 492 units of ZTS stock worth $87,965 on 30 October 2023.. The largest trade Nicholas's ever made was exercising 492 units of Zoetis Inc …Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Zoetis Announces First Quarter 2022 Results. Reports Revenue of $2.0 Billion, Growing 6%, and Net Income of $595 Million, or $1.26 per Diluted Share, Increasing 6% and 8%, Respectively, on a Reported Basis for First Quarter 2022. Delivers 9% Operational Growth in Revenue and 8% Operational Growth in Adjusted Net Income for First Quarter 2022.

Astorga Ferran ZTS stock SEC Form 4 insiders trading. Astorga has made over 1 trades of the Zoetis Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Astorga exercised 308 units of ZTS stock worth $50,256 on 30 September 2023.. The largest trade Astorga's ever made was exercising 308 units of …On February 5, 2023, Zoetis terminated Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at Zoetis Inc. (the "Company"), for violating company policy by engaging in a consensual personal relationship and failing to disclose it to the Company. Mr.The surge in investment and spending in global medicine is fueling the pharma industry. Therefore, investors could consider investing in quality pharma stocks Zoetis Inc. (ZTS), Wave Life Sciences Ltd. (WVE), and Johnson & Johnson (JNJ).The IQVIA Institute for Human Data Science predicts a surge in global medication spending, …At Zoetis, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Instagram:https://instagram. health insurance providers in massachusettsamex vanguardtrade futures with small accountai.c3 stock Zoetis Inc (ZTS) stock has gained 0.48% while the S&P 500 is down -0.74% as of 3:11 PM on Thursday, Nov 9. ZTS is higher by $0.82 from the previous closing price of $170.90 on volume of 2,430,877 shares. Over the past year the S&P 500 has gained 13.65% while ZTS is higher by 26.07%. ZTS earned $4.92 a per share in the over the last 12 months ... how do you know if a coin is uncirculatedtslq etf Find the latest Zoetis Inc. (ZTS) stock quote, history, news and other vital information to help you with your stock trading and investing. ljim May 4, 2023 · Zoetis Announces First Quarter 2023 Results. May 4, 2023. Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $552 Million, or $1.19 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for First Quarter 2023. Delivers 4% Operational Growth in Revenue and a 3% Operational Decline in Adjusted Net Income for First ... View the latest Zoetis Inc. (ZTS) stock price, news, historical charts, analyst ratings and financial information from WSJ.Zoetis Declares Fourth Quarter 2023 Dividend. PARSIPPANY, N.J., October 12, 2023--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the fourth ...